{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:27:12Z","timestamp":1785353232210,"version":"3.55.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"crossref","award":["J3-9280"],"award-info":[{"award-number":["J3-9280"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Our aim was to present the experience of systematic, routine use of next generation sequencing (NGS) in clinical diagnostics of myopathies.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>Exome sequencing was performed on patients with high risk for inherited myopathy, which were selected based on the history of the disease, family history, clinical presentation, and diagnostic workup. Exome target capture was performed, followed by sequencing on HiSeq 2500 or MiSeq platforms. Data analysis was performed using internally developed bioinformatic pipeline.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>The study comprised 86 patients, including 22 paediatric cases (26%). The largest group were patients referred with an unspecified myopathy (47%), due to non-specific or incomplete clinical and laboratory findings, followed by congenital myopathies (22%) and muscular dystrophies (22%), congenital myotonias (6%), and mitochondrial myopathies (3%). Altogether, a diagnostic yield was 52%; a high diagnostic rate was present in paediatric patients (64%), while in patients with unspecified myopathies the rate was 35%. We found 51 pathogenic\/likely pathogenic variants in 23 genes and two pathogenic copy number variations.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusion<\/jats:title><jats:p>Our results provide evidence that phenotype driven exome analysis diagnostic approach facilitates the diagnostic rate of complex, heterogeneous disorders, such as myopathies, particularly in paediatric patients and patients with unspecified myopathies.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0252953","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T18:14:22Z","timestamp":1623262462000},"page":"e0252953","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diagnostic yield of exome sequencing in myopathies: Experience of a Slovenian tertiary centre"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6071-4430","authenticated-orcid":true,"given":"Ivana","family":"Babi\u0107 Bo\u017eovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Maver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7522-5293","authenticated-orcid":true,"given":"Lea","family":"Leonardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Meznaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2188-420X","authenticated-orcid":true,"given":"Damjan","family":"Osredkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borut","family":"Peterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"pone.0252953.ref001","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511674747","volume-title":"Disorders of Voluntary Muscle","author":"G Karpati","year":"2010","edition":"8"},{"issue":"12","key":"pone.0252953.ref002","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.nmd.2016.11.010","article-title":"The 2017 version of the gene table of monogenic neuromuscular disorders (nuclear genome)","volume":"26","author":"JC Kaplan","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"pone.0252953.ref003","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg3463","article-title":"Disease-targeted sequencing: a cornerstone in the clinic","volume":"14","author":"HL Rehm","year":"2013","journal-title":"Nat Rev Genet"},{"issue":"5","key":"pone.0252953.ref004","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/WCO.0000000000000371","article-title":"Next-generation sequencing approaches for the diagnosis of skeletal muscle disorders","volume":"29","author":"V Nigro","year":"2016","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"pone.0252953.ref005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24303","article-title":"A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield","volume":"77","author":"A Ankala","year":"2015","journal-title":"Ann Neurol"},{"issue":"4","key":"pone.0252953.ref006","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00415-016-8036-0","article-title":"Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophy","volume":"263","author":"M Kuhn","year":"2016","journal-title":"J Neurol"},{"issue":"3","key":"pone.0252953.ref007","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/jnnp-2014-309663","article-title":"Improving molecular diagnosis of distal myopathies by targeted next-generation sequencing","volume":"87","author":"A Sevy","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"pone.0252953.ref008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.0000000000002800","article-title":"The genetic basis of undiagnosed muscular dystrophies and myopathies: results from 504 patients","volume":"87","author":"M Savarese","year":"2016","journal-title":"Neurology"},{"key":"pone.0252953.ref009","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.nmd.2015.03.002","article-title":"A comprehensive genetic diagnosis of Chinese muscular dystrophy and congenital myopathy patients by targeted next-generation sequencing","volume":"25","author":"Y Dai","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"pone.0252953.ref010","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jamaneurol.2015.2274","article-title":"Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy Outcomes and Lessons Learned","volume":"72","author":"R Ghaoui","year":"2015","journal-title":"JAMA Neurol"},{"key":"pone.0252953.ref011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13023-015-0364-0","article-title":"Next generation sequencing in a large cohort of patients presenting with neuromuscular disease before or at birth","volume":"10","author":"EJ Todd","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"pone.0252953.ref012","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/mus.24344","article-title":"Exome sequencing as a second-tier diagnostic approach for clinically suspected dysferlinopathy patients","volume":"50","author":"M Bartoli","year":"2014","journal-title":"Muscle Nerve"},{"issue":"1","key":"pone.0252953.ref013","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ana.24687","article-title":"Diagnosis and etiology of congenital muscular dystrophy: We are halfway there","volume":"80","author":"GL O\u2019Grady","year":"2016","journal-title":"Ann Neurol"},{"issue":"9","key":"pone.0252953.ref014","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41436-020-0840-3","article-title":"Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness","volume":"22","author":"A T\u00f6pf","year":"2020","journal-title":"Genet Med"},{"key":"pone.0252953.ref015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cge.12826","article-title":"Discovery of pathogenic variants in a large Korean cohort of inherited muscular disorders","volume":"91","author":"HJ Park","year":"2017","journal-title":"Clin Genet"},{"key":"pone.0252953.ref016","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.nmd.2019.08.003","article-title":"Genetic and phenotypic characterisation of inherited myopathies in a tertiary neuromuscular centre","volume":"29","author":"E Bugiardini","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"pone.0252953.ref017","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1212\/NXG.0000000000000212","article-title":"Diagnostic utility of exome sequencing in the evaluation of neuromuscular disorders","volume":"4","author":"GT Haskell","year":"2018","journal-title":"Neurol Genet"},{"issue":"2","key":"pone.0252953.ref018","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JND-160151","article-title":"Targeted Re-Sequencing Emulsion PCR Panel for Myopathies: Results in 94 Cases","volume":"3","author":"J Punetha","year":"2016","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"pone.0252953.ref019","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1212\/NXG.0000000000000408","article-title":"Molecular diagnosis of muscular diseases in outpatient clinics: A Canadian perspective","volume":"6","author":"F Thuriot","year":"2020","journal-title":"Neurol Genet"},{"issue":"4","key":"pone.0252953.ref020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jmoldx.2018.04.001","article-title":"A Reliable Targeted Next-Generation Sequencing Strategy for Diagnosis of Myopathies and Muscular Dystrophies, Especially for the Giant Titin and Nebulin Genes","volume":"20","author":"R Zenagui","year":"2018","journal-title":"J Mol Diagn"},{"key":"pone.0252953.ref021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41525-017-0006-7","article-title":"Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases","volume":"2","author":"D Schofield","year":"2017","journal-title":"NPJ Genom Med"},{"issue":"5","key":"pone.0252953.ref022","doi-asserted-by":"crossref","first-page":"e1205","DOI":"10.1002\/mgg3.1205","article-title":"Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients","volume":"8","author":"MHY Tsang","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"D1","key":"pone.0252953.ref023","doi-asserted-by":"crossref","first-page":"D865","DOI":"10.1093\/nar\/gkw1039","article-title":"The Human Phenotype Ontology in 2017","volume":"45","author":"S K\u00f6hler","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"pone.0252953.ref024","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/gim.2016.64","article-title":"Phenotype-driven gene target definition in clinical genome-wide sequencing data interpretation","volume":"18","author":"A Maver","year":"2016","journal-title":"Genet Med"},{"issue":"3","key":"pone.0252953.ref025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/gim.2017.142","article-title":"Comprehensive use of extended exome analysis improves diagnostic yield in rare disease: a retrospective survey in 1,059 cases","volume":"20","author":"G Bergant","year":"2018","journal-title":"Genet Med"},{"issue":"11","key":"pone.0252953.ref026","doi-asserted-by":"crossref","first-page":"e78496","DOI":"10.1371\/journal.pone.0078496","article-title":"Increasing the Yield in Targeted Next-Generation Sequencing by Implicating CNV Analysis, Non-Coding Exons and the Overall Variant Load: The Example of Retinal Dystrophies","volume":"8","author":"T Eisenberger","year":"2013","journal-title":"PLoS One"},{"key":"pone.0252953.ref027","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genet Med"},{"key":"pone.0252953.ref028","article-title":"ACGS","author":"S Ellard","year":"2020","journal-title":"best practice guidelines for variant classification 2020: association for clinical genetics science (ACGS)"},{"key":"pone.0252953.ref029","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/gim.2013.183","article-title":"Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory","volume":"16","author":"SP Strom","year":"2014","journal-title":"Genet Med"},{"key":"pone.0252953.ref030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajhg.2015.05.020","article-title":"The Human Phenotype Ontology: Semantic Unification of Common and Rare Disease","volume":"97","author":"T Groza","year":"2015","journal-title":"Am J Hum Genet"},{"key":"pone.0252953.ref031","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ncl.2014.04.004","article-title":"Distal Myopathies","volume":"32","author":"MM Dimachkie","year":"2014","journal-title":"Neurol Clin"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T18:29:49Z","timestamp":1699122589000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252953"}},"subtitle":[],"editor":[{"given":"Mathias","family":"Toft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252953","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]}}}